Tus kws kho mob
QP64R2-20 Update: Medical Drug Update for Viltolarsen (Viltepso)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2261 - 2270 ntawm 3159
Tus kws kho mob
QP107-20 Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2021
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Tus kws kho mob
QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 11, 2020
Tus kws kho mob
P50R2-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment and Post-Acute Care Services for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P49R1-20 CERiS Review of High Dollar Claims
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P78-20 Reminder: New Prior Authorization Timeframes Required by Legislation
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P84-20 Predetermination Request Form for Commercial Lines of Business
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P86-20 Appeals Policy for no Prior Authorization for Minnesota Health Care Programs
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
2020 November Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020
Tus kws kho mob
P81-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 02, 2020